Little Green Pharma Ltd (ASX:LGP) Annual Report 2025



The latest annual report of Little Green Pharma Ltd (LGP) was published on 31 Mar 2025. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - LGP Annual Results

Amounts in AUD

Total Revenue
$36.82M
Gross Profit
$27.57M
EBIT
$1.18M
Net Tangible Assets
$85.89M
Net Income
$3.32M
Capital Expenditures
-

LGP Income Statement 2025 Annual Report

As per the latest Income Statement of LGP, the Net revenue increased by $11.19M (44%) compared to the previous period. The operating income in 2025 increased by - (-). The net income as per the annual report was $3.32M which increased by $11.48M (141%) compared to previous year.

Income Statement Report (2025/2024)

2025 2024
Total Revenue $36.82M $25.63M
Gross Profit $27.57M $27.57M
Operating Income - -
Income Before Tax - -
Net Income $3.32M $-8.15M

Balance Sheet - LGP 2025 Annual Report

Read further: LGP Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Little Green Pharma Ltd showed the company increased the cash on balance sheet by $0.00 (0%). The Net tangible assets of LGP on the balance sheet were at $85.89M which is $0.00 (0%) more than previous annual report. The total stockholder equity also increased by - (-) compared to previous reporting period.

Balance Sheet Statement Report (2025/2024)

2025 2024
Cash $2.30M $2.30M
Total Assets - -
Long Term Debt - -
Total Liabilities $4.92M $4.92M
Total Shareholder Equity - -
Net Tangible Assets $85.89M $85.89M

Cash Flow Statement - LGP 2025 Annual Report

The 2025 annual cash flow statement of Little Green Pharma Ltd showed that the net income increased by $11.48M (141%) compared to previous reporting period. Also the capital expenditure of LGP increased by - (-).

As of 2025, the total cash from investing activities was - and total cash from financing activities was -.

Cash Flow Statement Report (2025/2024)

2025 2024
Net Income $3.32M $-8.15M
Capital Expenditures - -
Dividends Paid - -
Total Cash From From Investing Activities - -
Total Cash From From Financing Activities - -

Little Green Pharma Ltd Annual Report History

Income Statement

Income Statement history of Little Green Pharma Ltd (ASX:LGP)

31 Mar 2025 31 Mar 2024 31 Mar 2022 30 Jun 2021
Total Revenue $36.82M $25.63M $0.00 $0.00
Cost Of Revenue $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $0.00
Research Development - - - -
Selling General Administrative - - - -
Non Recurring - - - -
Other Operating Expenses - - - -
Total Operating Expenses $0.00 $0.00 $0.00 $0.00
Operating Income - - - -
Total Other Income Expense Net - - - -
Ebit $0.00 $0.00 $0.00 $0.00
Interest Expense - - - -
Income Before Tax - - - -
Income Tax Expense $0.00 $0.00 $0.00 $0.00
Minority Interest - - - -
Net Income From Continuing Ops - - - -
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Charges - - - -
Other Items - - - -
Net Income $3.32M $-8.15M $-18.29M $24.60M
Net Income Applicable To Common Shares - - - -

Balance Sheet Statement

Balance Sheet Statement history of Little Green Pharma Ltd (ASX:LGP)

31 Mar 2025 31 Mar 2024 31 Mar 2022 30 Jun 2021
Cash $2.30M $2.30M - -
Total Assets - - - -
Total Liab $4.92M $4.92M - -
Long Term Debt - - - -
Total Stockholder Equity - - - -
Net Tangible Assets $85.89M $85.89M - -

Cash Flow Statement

Cash Flow Statement history of Little Green Pharma Ltd (ASX:LGP)

31 Mar 2025 31 Mar 2024 31 Mar 2022 30 Jun 2021
Net Income $3.32M $-8.15M - -
Capital Expenditures - - - -
Dividends Paid - - - -
Total Cashflows From Investing Activities - - - -
Total Cash From Financing Activities - - - -